From helping entrepreneurs define their go-to-market or intellectual property strategy, to assisting them in implementing the operational processes to scale their businesses, Safeguard provides portfolio companies with the valuable resources they need to reach the next level of success.
But don’t take our word for it. See what some of our portfolio companies have to say about Safeguard:
"Safeguard and Founders Equity’s active support provides AHS with the ability to focus on the fundamental competencies of our business and pursue strategic acquisitions which will stimulate higher revenue growth rates and ultimately facilitate enhanced, more valuable offerings for our customers." ~ Former CEO
"Our decision to partner with Safeguard Scientifics was based on their proven track record in growing successful companies. We have been, and continue to be, a successful, profitable company. Partnering with Safeguard will help us go further faster, because we now have access to their unique model, rich management support platform and an array of business resources that help entrepreneurial companies grow and thrive." ~ Rich Migram, Founder and CEO
"Safeguard’s technology expertise and resources as a publicly-traded firm, along with capital, will enable us to expand our business and accelerate our ability to meet top-tier ad agencies' specialized needs." ~ Joe Zawadzki, CEO, MediaMath, Inc.
"With Safeguard’s support, we will be able to deepen our customer focus by building a world class service delivery team and investing in product development for our industry-leading platform." ~ Ned Moore, CEO
"Our decision to partner with Safeguard Scientifics was based on their proven track record in growing successful technology companies." ~ Greg Boesel, President & Co-founder, Swaptree, Inc.
"Advanced BioHealing, Inc. was seeking a partner that shared our vision for how to grow our business in order to create and maximize value. Safeguard Scientifics is a well-established company that has the capital resources necessary to support emerging growth companies, and has a track record for helping revenue-stage companies achieve these goals." ~ Kevin Rakin, CEO
“This is an exciting time for the Alverix team. Now, as an independent company, made possible by Safeguard Scientifics and New Venture Partners, we are well positioned to further develop and commercialize our products. Our ultimate goal is to revolutionize POC diagnostic testing, allowing physicians and eventually patients to better monitor and manage their healthcare needs with the confidence that the results can be used for immediate treatment." ~ Patrick T. Petruno, Founder and COO
"Every new technology needs a strong advocate, and that’s what we found with Safeguard Scientifics and our other financial partners. With their support, we believe that we’ll be successful in developing a test capable of accurately diagnosing Alzheimer’s disease and providing the basis for initiating therapy and monitoring response, representing a major shift in the diagnosis and treatment of neurodegenerative diseases." ~ Dan Skovronsky, MD, PhD, CEO and President
"Safeguard’s extensive commercial experience in the life sciences space complements our deep technical knowledge. As a result of this financing, our company will continue to flourish in this next growth phase, as we reap the benefits of access to Safeguard’s strategic, operational, and management resources. It promises to be an exciting and productive partnership." ~ Dr. Lansing Taylor, President and CEO
"Safeguard has a track record of successful partnerships within life sciences, and the necessary expertise to further the development of emerging regenerative medicine technologies." ~ Gerri Henwood, CEO, Garnet Biotherapeutics, Inc.
"Identifying healthy and viable embryos for transfer, and improving the success rate of IVF, are the Holy Grail for patients and physicians. Our partnership with Safeguard will help us to achieve this milestone." ~ Jim Posillico, PhD, President and CEO, Molecular Biometrics, Inc.
“The development of drug delivery alternatives designed to make current therapies safer and more effective is a core focus of NuPathe’s business platform. With this financing, we are well positioned to advance our clinical programs aggressively in the years ahead." ~ Jane Hollingsworth, Co-Founder and CEO "Safeguard’s unique focus on regenerative medicine and overall experience in the life sciences will complement our technical know-how and provide excellent insight and strategic vision going forward." ~ Steven Nichtberger, MD, Co-Founder, President and CEO, Tengion, Inc.
Privacy Policy
Copyright © 2010 Safeguard Scientifics, Inc. All rights reserved.